Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Elevation Oncology, Inc. ELEV

Full chart Compare
Set alert

Price alert · ELEV

All alert types
0.37 0.00 (+0.00%)

At closeJul 23, 2025, 4:00 PM EDT

0.365 Day range 0.365
0.44 52-week range 5.83

Financial health

Altman Z-Score

-4.75 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.7×
FY 2019: -45.8×FY 2020: -15.7×FY 2021: -4.4×FY 2022: -0.2×FY 2023: -0.4×FY 2024: -0.7×
FY 2019 5y median -0.7× FY 2024
P/S 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024
P/B 0.5×
FY 2019: -46.3×FY 2020: -11.8×FY 2021: 1.0×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 0.5×
FY 2019 5y median 0.5× FY 2024
P/FCF -0.9×
FY 2019: -49.9×FY 2020: -22.0×FY 2021: -4.6×FY 2022: -0.3×FY 2023: -0.3×FY 2024: -0.9×
FY 2019 5y median -0.9× FY 2024
EV/EBITDA -0.3×
FY 2019: -117×FY 2020: -11.2×FY 2021: 0.2×FY 2022: -0.1×FY 2023: 0.0×FY 2024: -0.3×
FY 2019 5y median -0.1× FY 2024
EV/Sales 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024
FCF Yield -112.9%
FY 2019: -2.0%FY 2020: -4.6%FY 2021: -21.6%FY 2022: -387.1%FY 2023: -307.0%FY 2024: -112.9%
FY 2019 5y median -112.9% FY 2024

Profitability

Gross Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
ROE -74.1%
FY 2019: 100.2%FY 2020: 74.8%FY 2021: -22.8%FY 2022: -193.9%FY 2023: -83.4%FY 2024: -74.1%
FY 2019 5y median -74.1% FY 2024
ROIC -49.0%
FY 2019: -446.6%FY 2020: -23.3%FY 2021: -22.8%FY 2022: -120.5%FY 2023: -53.5%FY 2024: -49.0%
FY 2019 5y median -49.0% FY 2024
ROA -46.5%
FY 2019: -307.3%FY 2020: -21.3%FY 2021: -21.4%FY 2022: -101.0%FY 2023: -51.3%FY 2024: -46.5%
FY 2019 5y median -46.5% FY 2024

Growth (YoY)

Revenue 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 FY 2024
Operating Income 1.6%
FY 2019: 0.0%FY 2020: -193.7%FY 2021: -85.5%FY 2022: -195.0%FY 2023: 51.9%FY 2024: 1.6%
FY 2019 FY 2024
EPS (diluted) 41.8%
FY 2019: 0.0%FY 2020: -192.0%FY 2021: -89.0%FY 2022: -196.4%FY 2023: 67.2%FY 2024: 41.8%
FY 2019 FY 2024
Free Cash Flow 35.3%
FY 2019: 0.0%FY 2020: -127.0%FY 2021: -143.9%FY 2022: -183.7%FY 2023: 34.3%FY 2024: 35.3%
FY 2019 FY 2024

Financial Health

Current Ratio 21.2×
FY 2019: 3.2×FY 2020: 11.9×FY 2021: 17.0×FY 2022: 5.9×FY 2023: 21.2×FY 2024: 21.2×
FY 2019 5y median 17.0× FY 2024
Quick Ratio 21.2×
FY 2019: 3.2×FY 2020: 11.9×FY 2021: 17.0×FY 2022: 5.9×FY 2023: 21.2×FY 2024: 21.2×
FY 2019 5y median 17.0× FY 2024
Debt / Equity 0.5×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.6×FY 2023: 0.5×FY 2024: 0.5×
FY 2019 5y median 0.5× FY 2024
Net Debt / EBITDA 0.4×
FY 2019: 0.8×FY 2020: 4.6×FY 2021: 4.6×FY 2022: 0.2×FY 2023: 0.5×FY 2024: 0.4×
FY 2019 5y median 0.5× FY 2024
Interest Coverage -11.2×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -197×FY 2023: -10.9×FY 2024: -11.2×
FY 2019 5y median -10.9× FY 2024

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31